Effect of Head-neck Rotation on I-gel™ Insertion

Sponsor
Seoul National University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05201339
Collaborator
(none)
172
1
2
5.1
33.8

Study Details

Study Description

Brief Summary

According to previous studies, head and neck rotation reduces the tongue from being rolled back by gravity, which resulted in increasing patency of the upper airway. Therefore, the purpose of this study is to verify whether head and neck rotation increases the first attempt success rate of i-gel™.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Standard method
  • Procedure: Hean and Neck Rotation
N/A

Detailed Description

I-gel™ insertion has been reported that the success rate of insertion on the first attempt is 78.5%. There may be several causes of insertion failure. Tongue folding is a major obstacle preventing appropriate i-gel™ placement. To solve this problem, the previous study has proven the efficacy of the rotational technical for I-gel™ insertion and reported a success rate of 97%.

However, the rotation of i-gel™ in the oral cavity may be limited, and it may take some learning curve to get used to it. According to previous studies, head and neck rotation increases the cross-sectional area of the upper airway, which resulted in increasing patency of the upper airway. Therefore, the purpose of this study is to verify whether head and neck rotation increases the first attempt success rate of i-gel™.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
172 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effect of Head-neck Rotation on the Success Rate at First Attempt of I-gel™ Insertion
Actual Study Start Date :
Feb 25, 2022
Anticipated Primary Completion Date :
Jul 30, 2022
Anticipated Study Completion Date :
Jul 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Standard method

Insert I-gel™ according to the manufacturer's instruction. Take the sniffing position and gently move the i-gel™ along the hard palate to the soft palate and the posterior oropharynx.

Procedure: Standard method
Insert I-gel™ according to the manufacturer's instruction. Take the sniffing position and gently move the i-gel™ along the hard palate to the soft palate and the posterior oropharynx.

Experimental: Head-neck rotation

After rotating the patient's head and neck to the left maximally, insert the i-gel™ from the right side of the tongue to the midline. When the tip reaches the soft palate and oropharynx positions, turn the head and neck back to the neutral position.

Procedure: Hean and Neck Rotation
After rotating the patient's head and neck to the left maximally, insert the i-gel™ from the right side of the tongue to the midline. When the tip reaches the soft palate and oropharynx positions, turn the head and neck back to the neutral position.

Outcome Measures

Primary Outcome Measures

  1. First attempt success rate [Induction of anesthesia during intraoperative period]

    After the first attempt on insertion of i-gel™ without withdrawal or redirection, the effectiveness of the airway is judged based on a square-wave capnograph and no audible leak with peak airway pressures ≥ 10 cmH2O during manual ventilation.

Secondary Outcome Measures

  1. Second attempt success rate [Induction of anesthesia during intraoperative period]

    After the second attempt on insertion of i-gel™, the effectiveness of the airway is judged based on a square-wave capnograph and no audible leak with peak airway pressures ≥ 10 cmH2O during manual ventilation.

  2. Insertion time for successful insertion; s [Induction of anesthesia during intraoperative period]

    Time from insertion of i-gel™ into the oral cavity until appropriate placement.

  3. Time required for successful insertion; s [Induction of anesthesia during intraoperative period]

    Time insertion of i-gel™ into the oral cavity until After the first attempt on insertion of i-gel™ without withdrawal or redirection, the effectiveness of the airway is judged based on a square-wave capnograph and no audible leak with peak airway pressures ≥ 10 cmH2O during manual ventilation.

  4. Third attempt [Induction of anesthesia during intraoperative period]

    If the attempt of assigned method fails twice, then try third attempt.

  5. Third attempt success rate [Induction of anesthesia during intraoperative period]

    If the attempt of assigned method fails, but the third attempt is successful with another method.

  6. Manipulations required rate [Induction of anesthesia during intraoperative period]

    An assistant assists when all attempt fail.

  7. Change to intubation [Induction of anesthesia during intraoperative period]

    Conversion rate from insertion of i-gel™ to tracheal intubation.

  8. Blood staining after extubation [Induction of anesthesia during intraoperative period]

    Blood stating to evaluate the postoperative complication and outcome in patients received each intubation method during surgery

  9. Sore throat after extubation [Extubation during intraoperative period]

    Sore throat to evaluate the postoperative complication and outcome in patients received each intubation method during surgery

  10. Hoarseness after extubation [Extubation during intraoperative period]

    Hoarseness to evaluate the postoperative complication and outcome in patients received each intubation method during surgery

  11. Sore throat at 24 hours after surgery [24 hours after surgery (up to 24hours)]

    Sore throat to evaluate the postoperative complication and outcome in patients received each intubation method during surgery

  12. Hoarseness at 24 hours after surgery [24 hours after surgery (up to 24hours)]

    Hoarseness to evaluate the postoperative complication and outcome in patients received each intubation method during surgery

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • ASA Physical Status Classification Grade 1-3

  • Patients who can provide written consent to participate in clinical trials

  • Patients requiring the I-gel™ during surgery

Exclusion Criteria:
  • Outpatient surgery

  • Patients who have the neurologic disease or cognitive impairment

  • Patients who take antipsychotic drugs

  • Body mass index > 35 kg/m2

  • Mouth opening < 2.5 cm

  • Limited neck extension or cervical mobilization (Ex: Atlanto-axial subluxation, History of cervical spine surgery or head and neck surgery)

  • Those with a recent sore throat

  • Those with weak dentation

  • Patients at risk of aspiration (Ex: Pregnancy, Gastroesophageal reflux disease or hiatus hernia)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Seoul National University Hospital Seoul Korea, Republic of 03080

Sponsors and Collaborators

  • Seoul National University Hospital

Investigators

  • Study Director: Karam Nam, MD, Seoul National University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Karam Nam, MD, Seoul National University Hospital, Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT05201339
Other Study ID Numbers:
  • LMA_HNRotation
First Posted:
Jan 21, 2022
Last Update Posted:
May 9, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Karam Nam, MD, Seoul National University Hospital, Seoul National University Hospital

Study Results

No Results Posted as of May 9, 2022